WHO validates China's Sinovac COVID-19 vaccine for emergency use

2021-06-01 23:45:31Xinhua Editor : Wang Fan ECNS App Download
Special: Battle Against Novel Coronavirus

The World Health Organization (WHO) validated on Tuesday the CoronaVac COVID-19 vaccine developed by Chinese pharmaceutical company Sinovac Biotech for emergency use.

WHO recommends the vaccine for use in people 18 years and older, in a two-dose schedule with a spacing of two to four weeks, according to a statement.

The efficacy results showed that the Sinovac vaccine prevented symptomatic disease in 51 percent of those vaccinated, and prevented severe COVID-19 and hospitalization in 100 percent of the studied population, according to the WHO's Strategic Advisory Group of Experts on Immunization (SAGE).


Most popular in 24h

MoreTop news


Back to top Links | About Us | Jobs | Contact Us | Privacy Policy
Copyright ©1999-2021 All rights reserved.
Reproduction in whole or in part without permission is prohibited.